Disruptive Bloodwork Startup May Offer Mostly Vaporware
dmr001 writes: As seen previously, Palo Alto startup Theranos planned to put the power of affordable lab work directly in the hands of patients with tiny fingerprick samples taken at Walgreen's, with four hour turnaround. The company claimed their tests were "made possible by advances in the field of microfluidics." But they were cagey about methodology and didn't use FDA approved analyzers.
Now, the Wall Street Journal reports (paywalled) (among others) that all but one of Theranos' analyzers currently in use is off the shelf, and that their tiny samples may not always have been accurate. Typically cagey founder Elizabeth Holmes vigorously disputes the criticism of her $9 billion startup, but entrenched players like Quest Diagnostics and LabCorp (which do quite well charging orders of magnitude above Theranos' prices) are likely doing a happy dance.
Physicians worrying about patients bringing in their own carcinoembryonic antigen levels and Epstein Barr Virus panels to confirm their Internet diagnoses of cancer and chronic fatigue may also be breathing sighs of relief, albeit with bittersweet regret at the potential loss of the price advantage and milliliter samples.
Now, the Wall Street Journal reports (paywalled) (among others) that all but one of Theranos' analyzers currently in use is off the shelf, and that their tiny samples may not always have been accurate. Typically cagey founder Elizabeth Holmes vigorously disputes the criticism of her $9 billion startup, but entrenched players like Quest Diagnostics and LabCorp (which do quite well charging orders of magnitude above Theranos' prices) are likely doing a happy dance.
Physicians worrying about patients bringing in their own carcinoembryonic antigen levels and Epstein Barr Virus panels to confirm their Internet diagnoses of cancer and chronic fatigue may also be breathing sighs of relief, albeit with bittersweet regret at the potential loss of the price advantage and milliliter samples.
that all but one of Theranos' analyzers currently in use is off the shelf,
What. Wait.... Is it supposed to be on the shelf? Is there something missing?
TFA in Business Insider just complained about the membership of the Board of Directors (which is weird).
And finally, ** 10 billion dollars ** for a startup that does essentially the same thing as everybody else but maybe undercuts price and probably violates the law in 45 states?
I'm in the wrong business.
Faster! Faster! Faster would be better!
Further proof that, far more often than not, "disruptive" means ignoring the law for as long as humanly possible while hoping that your competitors can't (or won't) follow suit.
I can't wait for "disruptive" medicine as practiced by anyone with internet access and a hyperlink to WebMD.
Anything to disrupt Quest Diagnostics. I wouldn't use this new outfit because they sound sort of shady, but I won't do business with Quest either. Their prices are insanely high, and they always automatically bill the patient first instead of billing the insurance because they know the insurance will adjust it down to a contracted reasonable price. I have had to spend thousands of dollars of my time on the phone with this company just to get them to bill the insurance company. They have threatened me with debt collection over a debt which I would have happily paid if only they would submit it to the insurance company so I knew how much I actually owed. I certainly didn't owe them the full amount they stated. I have repeatedly told doctors not not to send my bloodwork to Quest, but I guess they are a monopoly or the doctors get kickbacks because they always send the bloodwork to them, without first getting signoff from you about which tests will be performed or getting agreement to pay from you.
If you are not allowed to question your government then the government has answered your question.
Even the best testing panels have only found markers for CFS in a statistical manner.
That is - you take a hundred people with CFS, a hundred people without CFS, and you can with certainty tell which group is which.
However, you can't with any useful result test a single individual.
The false positive rate is 45%, and the false negative rate is 45% or so.
CFS is not one disease, it is almost certainly many.
Silicon Valley and the media want so bad for a successful female "founder" that it hasn't gotten off its knees for this woman.
"10 years in stealth mode" is hilarious
Anyone else would have been laughed out of the room with what has come out about Theranos as of late. Claims too good to be true dreamt up by a college kid? Yep, they are probably too good to be true.
if you look carefully at many of her pictures, especially close-up shots, she looks like someone who wears a latex mask. Maybe it's Steve Jobs underneath, that would explain the voice and how she dresses.
lucm, indeed.
I'd rather trust 10B of funding than an article on the WSJ
That's what Enron shareholders used to say.
lucm, indeed.